منابع مشابه
Multi-Criteria Risk-Benefit Analysis of Health Care Management
Abstract Purpose of this paper: The objectives of this paper are two folds: (1) utilizing hierarchical fuzzy technique for order preference by similarity to ideal solution (TOPSIS) approach to evaluate the most suitable RFID-based systems decision, and (2) to highlight key risks and benefits of radio frequency identification technology in healthcare industry. Design/methodology/approach: R...
متن کاملmulti-criteria risk-benefit analysis of health care management
abstract purpose of this paper: the objectives of this paper are two folds: (1) utilizing hierarchical fuzzy technique for order preference by similarity to ideal solution (topsis) approach to evaluate the most suitable rfid-based systems decision, and (2) to highlight key risks and benefits of radio frequency identification technology in healthcare industry. design/methodology/approach: resear...
متن کاملThe realities of risk-cost-benefit analysis.
Formal analyses can be valuable aids to decision-making if their limits are understood. Those limits arise from the two forms of subjectivity found in all analyses: ethical judgments, made when setting the terms of an analysis, and scientific judgments, made when conducting it. As formal analysis has assumed a larger role in policy decisions, awareness of those judgments has grown, as have meth...
متن کاملRisk-benefit analysis of the treatment of unruptured intracranial aneurysms.
OBJECTIVES To determine under what circumstances repair of unruptured intracranial aneurysms may be beneficial. METHODS A life expectancy analysis of patients with unruptured aneurysms with and without repair based on prospective data from the International Study of Unruptured Intracranial Aneurysms (ISUIA). RESULTS Life years are lost at all ages by repairing anterior circulation aneurysms...
متن کاملIntegration of PKPD relationships into benefit-risk analysis.
AIM Despite the continuous endeavour to achieve high standards in medical care through effectiveness measures, a quantitative framework for the assessment of the benefit-risk balance of new medicines is lacking prior to regulatory approval. The aim of this short review is to summarise the approaches currently available for benefit-risk assessment. In addition, we propose the use of pharmacokine...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2012
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2012.04265.x